“`html
Summary of Clinical Trial on Shen Gui Capsules for Chronic Heart Failure
Study Overview
- Assessed the effectiveness and safety of Shen Gui capsules (SGCP) as an adjuvant treatment for chronic heart failure (CHF).
- Reviewed nine randomized controlled trials (RCTs) involving 888 CHF patients.
Key Findings
- Positive Effects: SGCP combined with conventional therapy showed significant improvements in left ventricular ejection fraction, effective rate, and reduction in biomarkers associated with CHF.
- Minimal Adverse Events: The study did not find a significant difference in the incidence of adverse events between the experimental and control groups.
Conclusion
- Practical Solutions: SGCP, when used alongside conventional CHF therapy, can safely improve heart function and treatment effectiveness for patients with CHF.
- Value: The study emphasizes the need for further high-quality research to validate these findings due to the overall low quality of evidence in the current literature.
“`
